DE69120715D1 - 21-Substituierte Pregnan-Derivate - Google Patents

21-Substituierte Pregnan-Derivate

Info

Publication number
DE69120715D1
DE69120715D1 DE69120715T DE69120715T DE69120715D1 DE 69120715 D1 DE69120715 D1 DE 69120715D1 DE 69120715 T DE69120715 T DE 69120715T DE 69120715 T DE69120715 T DE 69120715T DE 69120715 D1 DE69120715 D1 DE 69120715D1
Authority
DE
Germany
Prior art keywords
substituted
pregnan derivatives
pregnan
derivatives
substituted pregnan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69120715T
Other languages
English (en)
Other versions
DE69120715T2 (de
Inventor
Kimihiko Hori
Yasuto Suzuki
Tomoki Morioka
Shigeru Moriwaki
Osamu Hirota
Shuichi Tsuchiya
Tadashi Hase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Application granted granted Critical
Publication of DE69120715D1 publication Critical patent/DE69120715D1/de
Publication of DE69120715T2 publication Critical patent/DE69120715T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DE69120715T 1990-04-23 1991-04-17 21-Substituierte Pregnan-Derivate Expired - Fee Related DE69120715T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10725590 1990-04-23

Publications (2)

Publication Number Publication Date
DE69120715D1 true DE69120715D1 (de) 1996-08-14
DE69120715T2 DE69120715T2 (de) 1996-11-28

Family

ID=14454417

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69120715T Expired - Fee Related DE69120715T2 (de) 1990-04-23 1991-04-17 21-Substituierte Pregnan-Derivate

Country Status (3)

Country Link
US (1) US5116829A (de)
EP (1) EP0452914B1 (de)
DE (1) DE69120715T2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
CN1245982C (zh) * 1996-05-09 2006-03-22 阿姆瑞德手术有限公司 哮喘和气道疾病的治疗
EP1079859B1 (de) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunktionelle moleküle sowie darauf basierende therapien.
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US20060134149A1 (en) * 1999-07-23 2006-06-22 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US20020054895A1 (en) 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20140135372A1 (en) 2010-02-02 2014-05-15 Elliott Farber Compositions and methods of treatment of inflammatory skin conditions using allantoin
CU20110244A7 (es) 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
WO2018089373A2 (en) 2016-11-08 2018-05-17 Regeneron Pharmaceuticals, Inc. Steroids and protein-conjugates thereof
MX2019013690A (es) 2017-05-18 2020-01-27 Regeneron Pharma Conjugados de farmaco-proteina con ciclodextrina.
SG11202010909RA (en) 2018-05-09 2020-12-30 Regeneron Pharma Anti-msr1 antibodies and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2814632A (en) * 1957-02-21 1957-11-26 Schering Corp Steroid compounds and methods for their manufacture
IT1045260B (it) * 1970-06-09 1980-05-10 Sigma Tau Ind Farmaceuti Estere del triamcinolone acetonide per l impiego antiflogistico topico
FR2077750B1 (de) * 1970-02-11 1973-03-16 Clin Byla Ets
US3749712A (en) * 1970-09-25 1973-07-31 Sigma Tau Ind Farmaceuti Triamcinolone acetonide esters and process for their preparation
FR2231374B1 (de) * 1973-05-30 1976-10-22 Jouveinal Sa
FR2510582B1 (fr) * 1981-07-30 1986-05-30 Sipsy Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament
FR2600653B1 (fr) * 1986-06-24 1988-12-16 Pasteur Strasbourg Universite Composes de synthese associative d'acides amines soufres ou non soufres avec des derives du d-4 pregnene 3,20-dione ou avec des derives du d-1,4 pregnadiene 3,20-dione aux proprietes glucocorticoides et anti-inflammatoires, procedes d'obtention, compositions pharmaceutiques les contenant. proprietes pharmacologiques et applications

Also Published As

Publication number Publication date
EP0452914A3 (en) 1992-05-06
EP0452914A2 (de) 1991-10-23
US5116829A (en) 1992-05-26
EP0452914B1 (de) 1996-07-10
DE69120715T2 (de) 1996-11-28

Similar Documents

Publication Publication Date Title
DE69119329D1 (de) Actinonin-Derivate
FI925523A (fi) Hydroxi- och alkoxipyridinderivat
FI931357A (fi) Framstaellning av polyhydroxifettsyraamider i naervaro av loesningsmedel
FI932069A0 (fi) Injektionsspruta
DE69125099D1 (de) Indolderivate
ATE144765T1 (de) Hiv-hemmende benzenacetamidderivate
FI925033A0 (fi) Foerbaettrade bitumenemulsioner
DE69130255D1 (de) Oxadolderivate
DK0472733T3 (da) Phenantrenderivater
TR26336A (tr) SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
DE69120715D1 (de) 21-Substituierte Pregnan-Derivate
FI923779A (fi) Foerbaettringar i tillverkningen av nylongarn
ATA99891A (de) Vollauszug
FI931125A (fi) Fodring
FI931157A0 (fi) 5-trifluoracylamino-2-aryloxatzoler
FI932197A (fi) Semduramicinfoerblandning
FI924890A0 (fi) Hybridcellreceptor
BR9104543A (pt) Derivados de triazolpiridazina
FI931481A0 (fi) Lossningsanordning foer bulkmaterial
FI931702A (fi) Indenoindolefoereningar
NO173406C (no) Sentrifugalpumpeaggregat
FI924450A (fi) Tygrengoeringsfoerfarande
FI924296A (fi) Rengoeringsprodukter i vaetskeform
FI930123A (fi) Foerfarande foer anvaendning av oxiderade lipoproteiner i virusartade infektioner
FI932081A0 (fi) Gerotorpumpar

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee